Q2 2020 Holdings
Filed 2020-08-14 | 65 holdings | $430.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $174.3M | 925,000 | 40.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $84.9M | 2,014,858 | 19.7% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $51.6M | 2,084,883 | 12.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $38.5M | 170,926 | 8.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $30.8M | 250,000 | 7.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $17.9M | 370,000 | 4.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.4M | 1,566,361 | 4.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.0M | 1,000,000 | 3.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $234.1K | 6,606,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $201.6K | 1,765,560 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $142.4K | 3,363,377 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $93.4K | 2,959,264 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $87.2K | 2,075,905 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $68.0K | 400,000 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $52.7K | 1,928,315 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $50.0K | 975,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $48.5K | 675,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $48.4K | 7,000,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $45.5K | 1,094,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $36.9K | 1,733,583 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $36.3K | 607,000 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $35.8K | 2,383,673 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $35.1K | 2,325,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $34.5K | 765,400 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $33.9K | 2,287,782 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $33.3K | 2,562,358 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $33.0K | 4,075,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $31.8K | 6,205,882 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $31.7K | 1,121,327 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $31.3K | 2,202,812 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $30.9K | 7,034,598 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $30.7K | 1,466,051 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $29.0K | 1,300,000 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $24.4K | 9,600,000 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460E539 | $24.3K | 7,000,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $18.3K | 1,775,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $16.8K | 1,009,255 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $16.7K | 1,123,105 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $15.8K | 250,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $15.7K | 4,000,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $13.8K | 844,789 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $13.4K | 300,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $12.9K | 705,882 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $12.3K | 4,029,649 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $12.0K | 2,913,091 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $10.4K | 416,495 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $9.8K | 181,138 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $9.3K | 3,284,072 | 0.0% |
| Matinas Biopharma Hldgs Inc | COM | 576810105 | $8.9K | 11,478,634 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.5K | 600,000 | 0.0% |